Rallybio

This study aimed to gather information, not to test a treatment. Researchers followed over 14,000 pregnant women to learn how often they develop a specific immune response that can lead to a rare bleeding disorder in their babies. The goal was to better understand who is at risk …

This early-stage study tested the safety and how the body processes multiple doses of a new drug called RLYB116. It involved 16 healthy adults to see how well they tolerated the drug and to measure its levels and effects in the blood. The goal was to gather initial safety data be…